We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$512M
Cap. Flow %
15.52%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.4M
2
XLRN
Acceleron Pharma
XLRN
+$7.85M
3
BHC icon
Bausch Health
BHC
+$7.4M
4
ALB icon
Albemarle
ALB
+$6.62M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.61M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10M
3
AMGN icon
Amgen
AMGN
+$7.37M
4
CBRL icon
Cracker Barrel
CBRL
+$5.6M
5
COST icon
Costco
COST
+$5.44M

Sector Composition

Rank Sector Weight
1 Healthcare 3.28%
2 Communication Services 1.55%
3 Technology 0.91%
4 Consumer Discretionary 0.74%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDSI
926
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$36K ﹤0.01%
+10,000
New +$37.7K
QTNT
927
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$35K ﹤0.01%
+375
New +$46.8K
CZR icon
928
PUT
Caesars Entertainment
CZR
$6.06B
$34K ﹤0.01%
300
– –
UMC icon
929
United Microelectronic
UMC
$42.9B
$34K ﹤0.01%
3,000
-22,000
-88% -$236K
SLAI
930
CALL
DELISTED
SOLAI Ltd ADS
SLAI
$33K ﹤0.01%
+57
New +$30.3K
GSM icon
931
FerroAtlántica
GSM
$590M
$33K ﹤0.01%
3,800
-114,200
-97% -$778K
FBRX icon
932
PUT
Forte Biosciences
FBRX
$1.57B
$31K ﹤0.01%
+416
New +$230K
IRWD icon
933
CALL
Ironwood Pharmaceuticals
IRWD
$586M
$30K ﹤0.01%
2,300
-20,800
-90% -$269K
SAN icon
934
Banco Santander
SAN
$191B
$29K ﹤0.01%
8,001
– –
ET icon
935
Energy Transfer Partners
ET
$69.5B
$24K ﹤0.01%
2,500
-45,000
-95% -$432K
CLVS
936
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$22K ﹤0.01%
5,000
– –
SIOX
937
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$20K ﹤0.01%
+9,230
New +$20.1K
FBRX icon
938
Forte Biosciences
FBRX
$1.57B
$15K ﹤0.01%
+200
New +$111K
FBRX icon
939
CALL
Forte Biosciences
FBRX
$1.57B
$12K ﹤0.01%
+160
New +$88.6K
ALDX icon
940
PUT
Aldeyra Therapeutics
ALDX
$97.1M
$11K ﹤0.01%
+1,300
New +$11.9K
ENDP
941
CALL
DELISTED
Endo International plc
ENDP
$10K ﹤0.01%
+3,000
New +$10.6K
MGY icon
942
Magnolia Oil & Gas
MGY
$5.93B
$9K ﹤0.01%
500
-500
-50% -$7.56K
ADMA icon
943
ADMA Biologics
ADMA
$2.02B
$7K ﹤0.01%
5,900
-54,100
-90% -$75.8K
VG
944
CALL
DELISTED
Vonage Holdings Corporation
VG
$6K ﹤0.01%
400
– –
SENS icon
945
Senseonics Holdings Inc
SENS
$254M
$3K ﹤0.01%
50
-75
-60% -$5.09K
CRBP icon
946
PUT
Corbus Pharmaceuticals
CRBP
$165M
$2K ﹤0.01%
50
– –
NGM
947
PUT
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2K ﹤0.01%
+100
New +$2.2K
CRBP icon
948
Corbus Pharmaceuticals
CRBP
$165M
$1K ﹤0.01%
17
– –
SIOX
949
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
+500
New +$1.09K
SIOX
950
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
+500
New +$1.09K
36 37
38
39 40

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.